Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$298,029,223
+$93,997,111 QoQ
Shares Held
1,173,482
+40.6% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#157
of 4,676 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alyeska Investment Group, L.P. holds $909,020,667 across 5 Drug Manufacturers - General names. JNJ ranks #2 (32.8% of the industry book) .
All Filings in JNJ
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $298,029,223 | 1,173,482 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $204,032,112 | 834,692 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $194,199,603 | 938,389 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $138,197,048 | 745,319 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $82,873,137 | 542,541 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,177,285 | 133,727 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $120,623,058 | 834,069 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $118,597,776 | 731,814 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $62,268,252 | 426,028 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $97,286,850 | 615,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $59,561,200 | 380,000 | Shares | Sole | 2024-02-14 | |
| 2020-03-31 | $1,888,009 | 14,398 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||